Lessons in Herding Cats – Business Development Basics for Life Science Companies

Add this event to your calendar:
09/02/2016 12:30 09/02/2016 14:00 America/New_York Lessons in Herding Cats – Business Development Basics for Life Science Companies JLABS @ LabCentral , 700 Main Street , Cambridge , MA Johnson & Johnson Innovation, JLABS false DD/MM/YYYY
February
9
Event

Lessons in Herding Cats – Business Development Basics for Life Science Companies

JLABS @ LabCentral , 700 Main Street , Cambridge , MA

February 09, 2016 from 12:30 PM to 14:00 PM (EST)

$10 - $35


The business development professional's purpose is to optimize optionality and long term value at each stage of a company's life. As a company grows and gains traction, it's easy to get enticed and overwhelmed by the numerous opportunities that arise. How do you determine the direction that will add the most value to your company? How do you avoid the constant pursuit of "shiny objects?" How do you know when it's the right time for a strategic partnership?

In this workshop, you'll learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities.

Topics will include:

  • Strategic alliance process management
  • Concepts in valuation
  • Importance of IP and IP diligence
  • Communication and negotiation skills
  • Basic components of a contract

This workshop is geared towards business development professionals and management teams of life science startups.


Speakers:
Parth Chakrabarti | Senior Director, Transactions, Johnson & Johnson Innovation read bio»
Scott Orchard | Senior Counsel, Johnson & Johnson Innovation read bio»


Agenda:
11:30 AM | Registration Opens, Networking & Lunch
12:00 PM | Presentations
12:45 PM | Q&A
1:00 PM | Program Close


Fees:
$35 | General Public
$20 | Student/Academic
$45 | Onsite


Location:
JLABS @ LabCentral
700 Main Street
Cambridge, MA


Speakers' biographies:

Parth Chakrabarti, MBA | Senior Director, Transactions, Johnson & Johnson Innovation
Parth is Senior Director of Transactions at Johnson & Johnson Innovation, Boston. During his 15 years in the healthcare industry, Parth has been passionate about innovation in science and in business/transaction models. Before joining Johnson & Johnson Innovation, Parth was a Director at Baxter BioScience where he helped build two new business units focused on oncology and specialty immunology entirely through licensing and external partnerships. Prior to that, he led the establishment of 'Innovation Cell' at Becton Dickinson & Co. that successfully established new growth strategy for its Medical Surgical Systems business unit. He and his team then successfully executed the strategy through a combination of acquisitions and partnership agreements to build a new business franchise. Before Becton Dickinson, Parth was an Investment manager at VenturEast Capital, one of the few pure-play healthcare focused venture funds based in India that specialize in cross-border company creation through early stage equity investment. Before transitioning to the business side of healthcare, Parth spent 10 years as a scientist, most of it at Amgen Inc. working on variety of targets likes G-protein coupled receptor agonists and P-38 Kinase inhibitors as well as in a range of therapeutic areas like neuropathic pain, breast cancer & Alzheimer's disease. His research contributed to advancement of three candidates to clinical development. Parth is an inventor in 23 granted patents and has co-authored multiple peer-reviewed papers that have garnered more than 450 citations. He has a Master's degree in Healthcare Management from Harvard University, MBA from ISB, M. Pharm. (Medicinal Chemistry) from Indian Institute of Technology and a B. Pharm. from Nagpur University.
Connect with Parth: Connect on LinkedIn



Scott Orchard | Senior Counsel, Johnson & Johnson Innovation
Scott is Senior Counsel at Johnson & Johnson Innovation, Boston where he is engaged in the full range of strategic transactions, including options to license or acquire technology, collaborations and licenses, sponsored research and venture capital investments. Previously, Scott was employed by several major New England based law firms and as an in house lawyer at a publicly traded manufacturing company. In those capacities, Scott advised public and private companies and private equity and venture capital firms on mergers and acquisitions, equity and debt financings, restructurings and other strategic and commercial transactions. Scott also has extensive experience counseling early stage companies and angel investors. Scott graduated from the University of Virginia School of Law and the University of California at Berkeley. Prior to law school Scott was an aide to U.S Senator William V. Roth, Jr. and a financial analyst in the investment banking division of Morgan Stanley & Co., Inc.
Connect with Scott: Connect on LinkedIn



Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), New York City, and with Shanghai opening in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact


Related content